疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

5 D1 T+ `: b: i; ]$ E- S% p

Vaccines, 6th Edition

. c3 X. h  [3 @, VApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
5 w: I, M. N8 ]- F
( [1 S0 u- L$ v+ D0 q/ @+ l) L* Whttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
6 P) y, F7 P+ p0 w  I( Y8 R9 y3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
! y2 J: z3 V. G! f% ]$ p" a* u6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
5 g9 Z# O" k1 i+ @; b9 [8 General immunization practices 88
4 j, d$ }- F( T  DSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
+ s' B2 L5 g0 c) ]6 @7 p12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
' v8 v  P5 \  X! ]/ v9 O/ G19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
  e; F6 S+ b; h; C21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
3 e. M) {* [" q3 Z; m; X24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
9 C) o+ X# ~5 @9 G/ }26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
9 D9 c( i, I( z" G+ G28 Poliovirus vaccine-live 598
. r/ h7 Q1 x( g, f# e29 Rabies vaccines .646
. o' s) {! i4 J' |' q! d. |30 Rotavirus vaccines . 669
31 Rubella vaccine 688
) B  K( P3 {" g/ @/ I32 Smallpox and vaccinia 718
1 \: o& T7 m( `33 Tetanus toxoid 746
# ?8 q1 @! ]  l34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
, U" t! ]4 K% N0 N36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
5 G' K5 ]! N7 A0 p. H$ Z7 F41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
7 `& M1 H6 ~/ Z44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
% `6 }4 P4 `1 {3 H47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
+ {# v0 \8 t: F& H+ u49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
$ [9 b4 i1 \! L; _" i" `7 i3 R51 Human immunodeficiency virus vaccines 1097
* [0 q. w  z( Z6 ?52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
( Y8 [) S$ u/ I+ C7 Q! n54 Noninfectious disease vaccines 1138
/ M0 f  r1 l) U5 `- Q+ v55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
7 S" |7 l9 ~- N' a$ N56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
: w1 E- s+ T0 \# Z! r" Y' G58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
9 X6 g+ D4 m4 J* z8 r+ t61 Alternative vaccine delivery methods 1200
9 m6 ^' ~, M6 l  z$ ~' R& m62 The development of gene-based vectors for immunization 1232
: Y) V1 R6 t1 K0 f: k" k. y% K: U! PSECTION 4: Vaccination of special groups
! b8 l, T" ]# {- U* p2 y7 k& K: J63 Vaccination of immunocompromised hosts 1243
" z$ ]! O. P) {5 L- D64 Vaccination of human immunodeficiency virus-infected persons 1257
2 _& X2 {& q. S, [65 Vaccines for international travel 1270
; ]# V$ x) M3 ]3 g) s, p# A66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
/ ^" Y$ @9 I$ k67 Immunization in the United States 1310
' {0 b: s1 o5 F/ T# i68 Immunization in Europe . 1334
& c4 s! A/ ^+ ]$ S6 h69 Immunization in the Asia-Pacific region 1353
2 Z* ~" }4 {9 t2 b% D4 `! d70 Immunization in developing countries 1369
+ F3 L+ o1 F2 [: Q) H71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
: m) \2 }/ ~  t3 r7 z74 Regulation of vaccines in Europe 1447
' e$ b) \: r2 c0 S75 Regulation of vaccines in developing countries 1454
& S& F; I/ e1 @; p76 Vaccine safety 1464
0 q, {* f$ i! m) L! |77 Legal issues . 1481
78 Ethics 1508

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
. n: j( ?% D+ Z0 ]3 Y
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link? ... 1&uk=3810996606

/ _" |$ H7 ?+ ^1 \* V9 {0 |SECTION 1: General aspects of vaccination
5 V/ [8 n+ T3 J( ^, G+ x1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
0 \- E' G$ ]4 d& W3 I$ R' R4 Q8 e5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
' |0 r" C5 q8 w$ |! H: clicensed vaccines 71
* E% C. w+ h5 _  ?7 Passive immunization 80
3 N1 D  W4 T6 ?  a0 P3 k* G8 General immunization practices 88
5 F6 q2 y% d1 v7 S! _# r% XSECTION 2: Licensed vaccines
  o; o/ M3 g6 s' }' @9 Adenovirus vaccines 113
10 Anthrax vaccines 127
5 ^# |* b; W8 y11 Cholera vaccines 141
9 C' r0 e, S0 w# l& Q% t3 s% s12 Diphtheria toxoid 153
0 g5 @$ L4 N7 a% g) w13 Haemophilus influenzae vaccines 167
6 H; c3 V; {7 i5 f4 x; B14 Hepatitis A vaccines 183
6 X4 }4 k7 M# Z8 [0 A" J15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
( Z/ M& J# l- ~1 {' h0 ?17 Inactivated influenza vaccines 257
2 W$ s- F/ O! N" o4 ?9 O2 c18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
2 F0 [& X7 o" H8 I) u9 t8 F21 Meningococcal vaccines 388
2 Z! D% |5 N1 R3 ^4 r" B. c22 Mumps vaccine 419
! H: Q. ], y" a) S  W: D23 Pertussis vaccines . 447
/ \* H; p' ^8 Z9 p. ~0 I- ~  S24 Plague vaccines 493
# y1 K* q; _& M7 ]1 j' V, ?25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
. C$ o( ]6 \6 b% s' b26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
- v' j& Z4 r: d& J1 H30 Rotavirus vaccines . 669
8 c6 k% \9 W$ z0 ~31 Rubella vaccine 688
32 Smallpox and vaccinia 718
' I# m" i; M) d8 x, q0 ^' D! Y33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
  @% a! s! E4 [% ^: Q' ?# h35 Tuberculosis vaccines 789
- u' T' R4 v5 ^' F% W/ q7 v1 l36 Typhoid fever vaccines 812
37 Varicella vaccine 837
/ O! d3 @0 a/ x) f38 Yellow fever vaccine 870
! N8 B  E3 o7 Z5 L39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
# C! J1 n* a0 f9 G9 g41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
" }* d9 e5 W, Y+ k45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
3 T, p" W3 ]% N47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
) q8 e* ]3 @( ~0 e0 I# }7 Z" e8 y2 f2 y51 Human immunodeficiency virus vaccines 1097
+ M' G. M) J, R1 ?. ]# X52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
" y" O( J7 @5 |- \( k+ `54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
; d9 e( |$ q3 {+ l( o7 d56 Parasitic disease vaccines 1154
# j+ a, K! A, \+ ]/ v4 c; d57 Staphylococcus aureus vaccines 1161
; O/ U- p0 Q; g0 l' p) }) E58 Streptococcus group A vaccines 1169
3 I. l% p7 ?4 y/ N' d; M0 M7 j" Z59 Streptococcus group B vaccines 1176
" N  Q% B9 y0 |/ d9 }+ a60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
3 a: S% P" G( ]8 q# C3 OSECTION 4: Vaccination of special groups
4 E1 A* K# _7 [1 `0 ^63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
; Q* e  @/ a8 M6 j0 K66 Vaccines for health care personnel 1290
; X; v' I; e* h3 U, m0 \SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
1 o8 z7 J# P  C/ v' N+ v69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
6 l  S, r9 [* v! {72 Economic analyses of vaccine policies 1413
2 k2 G$ D9 I5 }$ z73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
8 {7 g) x# O- o. @77 Legal issues . 1481
78 Ethics 1508
) }7 V) ^4 _1 ^4 S' h0 o
8 w- \5 G& D. R& h) B

casarett

Vaccines, 6e, 2012

2 x4 K! \* K( b5 Y6 t; l) ^' _Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
, E4 b( @4 N) |* H4 }' L% GLanguage: English
' {5 X- X0 Z9 @, ]) u  ^3 f. zISBN-10: 1455700908
+ t, F9 R8 D3 ?+ l9 K; W: j; LSize: 52.3mb (original pdf)
+ u+ p/ e9 |! Y. v1 r
' J2 C2 X& T; `( y  R! M5 x3 q5 q2013 BMA Medical Book Awards Highly Commended in Public Health!
0 F- w% |% }& TApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

7 ?$ t0 h1 v- A. b4 zGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
+ X# U# l; g) S2 U( J- ]3 uGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
/ A! {9 t6 x: v# X4 k3 ]Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
4 D' |/ b0 D- F1 B  A
Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96
6 ~  v* B8 j/ j  J$ q2 M